The US Food and Drug Administartion (FDA) has approved Venus Concept's Venus Swan device to treat Facial Wrinkles and Rhytides.

The Venus Swan device utilizes the company’s (MP)² technology in order to provide fast, pain free results for various aesthetic indications.

Venus Concept CEO Domenic Serafino said this clearance allows them to provide their technology to additional distribution channels that traditionally may not be associated with non invasive aesthetic treatments.